logo
Select company
Select metric
-319.33%EBITDA Margin
VS
Market
8
Sector
29
Industry
51
History
88
$ 6.48Close
$ 3 - $ 24.6 52-Week Range
Ticker Information

Ticker

GBIO

Company Name

GENERATION BIO CO

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

GENERATION BIO CO - EBITDA Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

GBIO - EBITDA % Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA MarginRevenues
6/30/2025$ -67.79M-319.33%$ 21.23M
3/31/2025$ -67.17M-273.55%$ 24.56M
12/31/2024$ -126.74M-637.13%$ 19.89M
9/30/2024$ -140.39M-755.53%$ 18.58M
6/30/2024$ -153.23M-1163.14%$ 13.17M
3/31/2024$ -163.81M-1644.22%$ 9.96M
12/31/2023$ -121.35M-2055.37%$ 5.9M
9/30/2023$ -118.55M-3917.61%$ 3.03M
6/30/2023$ -121.52M-13808.64%$ 880K
3/31/2023$ -128.47M0%$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • GENERATION BIO CO's latest trailing twelve months (TTM) EBITDA % stands at 0%.
  • Over the past 5 years, GENERATION BIO CO's average EBITDA % has been -2730.5%.
  • The median EBITDA % for GENERATION BIO CO during this period was -1163.14%
  • GENERATION BIO CO reached its highest EBITDA % over the past 5 years at -273.55%.
  • The lowest EBITDA % recorded by GENERATION BIO CO in the same timeframe -13808.64%

GENERATION BIO CO's EBITDA % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA % Benchmarks
CompanyEBITDA %
XLO : XILIO THERAPEUTICS INC -363.9%BCAB : BIOATLA INC -534.19%CRIS : CURIS INC -329.1%PRPO : PRECIPIO INC -0.44%MRSN : MERSANA THERAPEUTICS INC -188.64%DYAI : DYADIC INTERNATIONAL INC -123.19%XFOR : X4 PHARMACEUTICALS INC -271.2%NEPH : NEPHROS INC 8.95%POCI : PRECISION OPTICS CORPORATION INC -27.96%NRXS : NEURAXIS INC -218.34%

Definition of EBITDA Margin

[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
EBITDA / Revenues
(=) EBITDA %
EBITDA % for GENERATION BIO CO is calculated as follows: EBITDA [ $ -77.09M ] / Revenues [ $ 0 ]
(=) EBITDA % [ 0% ]

GBIO - EBITDA Margin, Last 5 years

-13808.64%

Minimum

Jun 30, 2023

-273.55%

Maximum

Mar 31, 2025

-2730.5%

Average

-1163.14%

Median

EBITDA % Benchmark Analysis

The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.2% with a standard deviation of 26.73%.
The following table provides additional summary stats:
EBITDA % in the Market:
filtered constituents3.29K
min-74.33%
max97.24%
average16.2%
median14.74%
std26.73%